PiPS2: A study investigating predictions about how long patients with advanced cancer have left to live

Not Applicable

Completed

• Conditions: Advanced incurable cancer; Cancer

• Registration Number: ISRCTN13688211
• Lead Sponsor: niversity College London

Brief Summary

2018 Protocol article in https://pubmed.ncbi.nlm.nih.gov/30103711/ protocol (added 30/11/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33909630/ (added 29/04/2021) 2021 Other publications in https://pubmed.ncbi.nlm.nih.gov/33952580/ recruitment analysis (added 07/05/2021) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/34018486/ (added 24/05/2021) 2022 Other publications in https://pubmed.ncbi.nlm.nih.gov/35421168/ Secondary analysis of doctors' accuracy (added 19/04/2022)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-06-28
• Study Completion: 2019-04-30
• Last Update Posted: 25 July 2023

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 1778

Inclusion Criteria

1. Participants with advanced incurable cancer
2. With or without capacity to consent to research
3. Aged 18 years or over
4. Have been recently referred to palliative care services

Exclusion Criteria

Currently receiving (or planned to receive) treatment with curative intent.

Study & Design

• Study Type: Observational
• Study Design: Not specified